BALCX
Price
$37.64
Change
+$0.20 (+0.53%)
Updated
Sep 5 closing price
Net Assets
257.73B
MSFFX
Price
$20.04
Change
-$0.04 (-0.20%)
Updated
Sep 5 closing price
Net Assets
7.78B
Interact to see
Advertisement

BALCX vs MSFFX

Header iconBALCX vs MSFFX Comparison
Open Charts BALCX vs MSFFXBanner chart's image
American Funds American Balanced C
Price$37.64
Change+$0.20 (+0.53%)
VolumeN/A
Net Assets257.73B
MFS Total Return R1
Price$20.04
Change-$0.04 (-0.20%)
VolumeN/A
Net Assets7.78B
BALCX vs MSFFX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
BALCX vs. MSFFX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BALCX is a Buy and MSFFX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
BALCX has more cash in the bank: 258B vs. MSFFX (7.78B). MSFFX pays higher dividends than BALCX: MSFFX (1.60) vs BALCX (1.16). BALCX was incepted earlier than MSFFX: BALCX (25 years) vs MSFFX (20 years). MSFFX (1.47) is less costly to investors than BALCX (1.31). MSFFX is a more actively managed with annual turnover of: 53.00 vs. BALCX (44.00). MSFFX has a lower initial minimum investment than BALCX: MSFFX (0) vs BALCX (250). BALCX annual gain was more profitable for investors over the last year : 9.12 vs. MSFFX (-0.05). BALCX return over 5 years is better than : 35.50 vs. MSFFX (7.24).
BALCXMSFFXBALCX / MSFFX
Total Expense Ratio1.311.4789%
Annual Report Gross Expense Ratio1.311.4789%
Fund Existence25 years20 years-
Gain YTD10.8357.357147%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets258B7.78B3,318%
Annual Yield % from dividends1.161.6073%
Returns for 1 year9.12-0.05-18,256%
Returns for 3 years37.2012.36301%
Returns for 5 years35.507.24491%
Returns for 10 years67.8529.72228%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JNGLX70.490.55
+0.79%
Janus Henderson Global Life Sciences D
JSVRX29.210.09
+0.31%
JPMorgan Small Cap Value R5
CICAX65.580.08
+0.12%
American Funds Invmt Co of Amer 529A
SGIGX35.36N/A
N/A
Steward Global Equity Income Fund R6
PAXGX17.67N/A
N/A
Impax Global Opportunities Investor